AC Immune
AC Immune
Game-Changing $21B Alzheimer’s Therapy Deal Sealed!
BIOT
AC Immune and Takeda join forces 🤝💼🧠, sealing a $2.1bn deal for ACI-24.060 therapy to combat Alzheimer's disease.
Roche Abandons AC Immune Collaboration Returns Drugs
BIOT
📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅
